-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cz0sAApFGnW3GDTuV3Eb3TwRb5npc2IrEKuCtn2rw0tJVmGrIKZYnJBrudWngukA A/6amFEoye9GZhFQYbnlcA== 0001085037-09-000056.txt : 20090123 0001085037-09-000056.hdr.sgml : 20090123 20090122173808 ACCESSION NUMBER: 0001085037-09-000056 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20090122 FILED AS OF DATE: 20090123 DATE AS OF CHANGE: 20090122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN CO LTD CENTRAL INDEX KEY: 0001135174 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-32359 FILM NUMBER: 09539951 BUSINESS ADDRESS: STREET 1: 4F, HEUNGSEONG BLDG. STREET 2: 197-3, JAMSILBON-DONG, SONGPA-GU CITY: SEOUL STATE: M5 ZIP: 00000 BUSINESS PHONE: 604-738-8119 MAIL ADDRESS: STREET 1: SUITE 306 STREET 2: 2150 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V6K 4L9 6-K 1 form6k012309.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of January, 2009

 

Commission File Number: 000-32359

 

MERIDIAN CO., LTD.

(Translation of registrant's name into English)

 

4F, Heungseong Bldg., 197-3, Jamsil-Dong, Songpa-Gu, Seoul, Korea

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x   Form 40-F o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes o No x

 

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_________

 

 


 

 


SUBMITTED HEREWITH

Exhibits

99.1

News release dated January 7, 2009 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MERIDIAN CO., LTD.

 

By:

/s/ Myeong, Hyeon-Seong

Myeong, Hyeon-Seong

President

Date: January 22, 2009

 

 

 

 

 EX-99 2 nr010709.htm

Meridian Receives FDA Approval

2009-01-07 16:56 ET - News Release

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- 01/07/09


Meridian Co., Ltd., (OTCBB: MRDAF) a company engaged in the research, development, manufacturing, and sales of advanced medical devices, is pleased to announce that they have received FDA clearance to market the Lapex BCS (Body Contouring System) laser device.

The FDA 510(k) Clearance has been granted based on our premarket notification for indications for the Use of "elevating tissue temperature and temporary relief of muscle and joint pain and stiffness, minor arthritis pain, or muscle spasm; the temporary increase in local blood circulation; and/or temporary relaxation of muscle".

The FDA Clearance allows us to market the Lapex BCS (Body Contouring System) which is a safe and pain free, non-invasive laser device, and is another important step in the ongoing marketing and development of Meridian's industry leading equipment.

Meridian is a leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval, Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe. Meridian continues to successfully market its superior product line to a growing number of clients worldwide.

For more information, please visit: http://www.meridianmedical.ca.

Safe Harbor Statement

This press release contains certain forward-looking information and statements concerning the company's future operations, performance and financial condition. These statements include that the Lapex BCS is a safe and pain free, non-invasive laser device; that FDA clearance is an important step in the ongoing marketing and development of Meridian's industry leading equipment; and that Meridian continues to successfully market its superior product line to a growing number of clients worldwide. Forward looking statements are subject to a number of risks, uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Risk factors which could prevent the foregoing statements from being accurate include possible accidents of use of our laser devices and possible lesser market acceptance of our medical devices than anticipated. The Company does not update its forward looking information. This document is not intended to be and is not an advertisement for any securities of the Company.

 

 


- 2 -

 

 

Contacts:

Meridian Co., Ltd.

Peter Holeczek

Corporate Communications

1-877-738-8119

Website: www.meridianmedical.ca

 

 

 

 

 

 GRAPHIC 3 img1.gif GRAPHIC begin 644 img1.gif M1TE&.#EA`0`!`'<``"'_"TU33T9&24-%.2XP&`````QM -----END PRIVACY-ENHANCED MESSAGE-----